In a recent SEC filing, Becton Dickinson & Co (NYSE:BDX), a leading medical technology company, announced the outcomes of its 2025 Annual Meeting held on Monday. Shareholders voted on several key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback